Developing AIDS vaccines has been a frustrating business. A vaccine that triggers immune responses that effectively control early infection by the simian counterpart of HIV in macaques seems promising. See Letter p.523
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Johnson, W. E. & Desrosiers, R. C. Annu. Rev. Med. 53, 499–518 (2002).
Barouch, D. H. Nature 455, 613–619 (2008).
Hansen, S. G. et al. Nature 473, 523–527 (2011).
Sallusto, F., Mackay, C. R. & Lanzavecchia, A. Annu. Rev. Immunol. 18, 593–620 (2000).
Moss, P. & Khan, N. Hum. Immunol. 65, 456–464 (2004).
Robinson, H. L. & Amara, R. R. Nature Med. 11, S25–S32 (2005).
Haase, A. T. Nature 464, 217–223 (2010).
Hansen, S. G. et al. Nature Med. 15, 293–299 (2009).
Heineman, T. C. et al. J. Infect. Dis. 193, 1350–1360 (2006).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Johnson, R. Persistence pays off. Nature 473, 456–457 (2011). https://doi.org/10.1038/473456a
Published:
Issue Date:
DOI: https://doi.org/10.1038/473456a